Responses to systemic and topical glucocorticoids in coeliac crisis

Documenti analoghi

• Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis
  di: Rakel Nurmi, et al.
  Pubblicazione: (2025)
• Development and validation of a predictive scoring system for hypoglycaemic agents for optimal control of blood glucose during glucocorticoid therapy
  di: Ayaka Kato, et al.
  Pubblicazione: (2024)
• Romosozumab versus denosumab in long‐term users of glucocorticoids: A pilot randomized controlled trial
  di: Chi Chiu Mok, et al.
  Pubblicazione: (2024)
• How should glucocorticoid and mineralocorticoid replacement be optimised in a young patient with classic 21‐hydroxylase congenital adrenal hyperplasia?
  di: Stephanie Teasdale, et al.
  Pubblicazione: (2025)
• Flare risk after oral glucocorticoid bridging with methotrexate or intra‐articular bridging with triple therapy in early rheumatoid arthritis
  di: Kristina Lend, et al.
  Pubblicazione: (2026)